# Filana Therapeutics, Inc.: Form 10-Q for the period ended Mar 31, 2026

- Company: [Filana Therapeutics, Inc.](/companies/flna.md) (CIK 1069530)
- Form: 10-Q
- Filed: 2026-05-07
- Accepted by EDGAR: May 7, 2026, 17:16 ET
- Period: 2026-03-31
- Accession: 0001437749-26-015664
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1069530/000143774926015664/sava20260331_10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1069530/000143774926015664/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2026-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Research and development | 3 months, 2026-01-01 to 2026-03-31 | $4.5m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2026-01-01 to 2026-03-31 | −$11.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months, 2026-01-01 to 2026-03-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2026-01-01 to 2026-03-31 | −$10.3m | us-gaap:NetIncomeLoss |
| Basic EPS | 3 months, 2026-01-01 to 2026-03-31 | −$0.21 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 3 months, 2026-01-01 to 2026-03-31 | −$8.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | at 2026-03-31 | $86.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2026-03-31 | $88.0m | us-gaap:AssetsCurrent |
| Total assets | at 2026-03-31 | $108.4m | us-gaap:Assets |
| Current liabilities | at 2026-03-31 | $40.1m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2026-03-31 | $40.2m | us-gaap:Liabilities |
| Shareholders' equity | at 2026-03-31 | $68.1m | us-gaap:StockholdersEquity |

## Sections

EDGAR did not return this filing’s main document when we asked, so its sections were not extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1069530/000143774926015664/sava20260331_10q.htm

Filed May 7, 2026.
Source: SEC EDGAR, the filing index for accession 0001437749-26-015664. Last ingested by Listed: Nov 5, 2026, 16:57 ET. No prices; not investment advice.